ArticleJournal of clinical laboratory analysis2022

METTL3-mediated m6A modification of lnc RNA RHPN1-AS1 enhances cisplatin resistance in ovarian cancer by activating PI3K/AKT pathway.

Shoubin CuiPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.